<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Pemphigus treatment &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/pemphigus-treatment/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Sat, 24 Jan 2026 10:33:08 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Pemphigus treatment &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Unexpected Rituximab Reactions in Pemphigus Patients</title>
		<link>https://bioengineer.org/unexpected-rituximab-reactions-in-pemphigus-patients/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sat, 24 Jan 2026 10:32:45 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Autoimmune therapy complications]]></category>
		<category><![CDATA[B-cell depletion side effects]]></category>
		<category><![CDATA[B-hücre tedavisi riskleri]]></category>
		<category><![CDATA[deri hastalığı tedavi zorlukları** * **pemfigüs tedavi komplikasyonları:** Makalenin ana konusu olan pemfigüs tedavis]]></category>
		<category><![CDATA[İşte 5 uygun etiket: **pemfigüs tedavi komplikasyonları]]></category>
		<category><![CDATA[otoimmün tedavi yan etkileri]]></category>
		<category><![CDATA[Pemphigus treatment]]></category>
		<category><![CDATA[rituksimab paradoksal etkileri]]></category>
		<category><![CDATA[Rituximab paradoxical reactions]]></category>
		<category><![CDATA[systematic review]]></category>
		<guid isPermaLink="false">https://bioengineer.org/unexpected-rituximab-reactions-in-pemphigus-patients/</guid>

					<description><![CDATA[Rituximab, an effective monoclonal antibody targeting CD20-positive B-cells, is widely utilized in the treatment of various autoimmune disorders, including pemphigus, a group of chronic blistering skin diseases. Pemphigus is characterized by the presence of autoantibodies directed against desmosomal proteins, leading to acantholysis and subsequent skin lesions. Despite the efficacy of rituximab in controlling disease activity [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">320259</post-id>	</item>
	</channel>
</rss>
